Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Image guided treatment optimalization with cetuximab for patients with metastatic colorectal cancer

Trial Profile

Image guided treatment optimalization with cetuximab for patients with metastatic colorectal cancer

Status: Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 04 Jul 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cetuximab (Primary) ; Zirconium-89 cetuximab (Primary) ; Panitumumab
  • Indications Adenocarcinoma; Colorectal cancer; Liver metastases
  • Focus Pharmacokinetics; Therapeutic Use
  • Acronyms IMPACT-CRC
  • Most Recent Events

    • 04 Jun 2024 Results assessing the predictive performance of early evaluation of metabolic rate with [18F]FDG PET/CT and baseline and after 1 intravenous anti-EGFR mAb administration to distinguish patients with and without clinical benefit, presented at the 60th Annual Meeting of the American Society of Clinical Oncology.
    • 07 Mar 2021 Status changed from recruiting to discontinued.
    • 05 Oct 2018 Planned End Date changed from 1 Dec 2017 to 1 Mar 2019.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top